Originally posted on 5/1/2013
As we like to do from time to time, we thought we would round up some recent partnership announcements from ASAP Corporate and Global Members. In particular, the biopharma industry members have been active this spring.
AstraZeneca and Bind Therapeutics entered into an alliance around Accurin, a cancer nanomedicine
. Merck and Pfizer are collaborating around a type 2 diabetes drug
that is set for Phase III.
And speaking of diabetes, Eli Lilly and Company's diabetes group is expanding its unique partnership with Disney
to bring educational resources about the disease to people all over the world. The partnership began exclusively as a U.S. initiative.